| Non Small Cell Lung Cancer | NSCLC | Pembrolizumab | PD-L1 | CD274 | clinical trial phase 2/3 | 29153898 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Nivolumab | PD-L1 | CD274 | clinical trial phase 3 | 29153898 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Nivolumab | PD-L1 | CD274 | clinical trial phase 3 | 29153898 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Pembrolizumab | PD-L1 | CD274 | clinical trial phase 3 | 29153898 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Atezolizumab | PD-L1 | CD274 | clinical trial phase 2 | 29153898 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Atezolizumab | PD-L1 | CD274 | clinical trial phase 3 | 29153898 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | M7824(Bintrafusp alfa) | mesenchymal fibronectin | FN1 | cell lines | 29123964 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | M7824(Bintrafusp alfa) | E-cadherin | CDH1 | cell lines | 29123964 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | M7825(Bintrafusp alfa) | Vimentin | VIM | cell lines | 29123964 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | M7825(Bintrafusp alfa) | Smad2 | SMAD2 | cell lines | 29123964 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | M7825(Bintrafusp alfa) | Smad3 | SMAD3 | cell lines | 29123964 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | PD-L1 | CD274 | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | PD-L1 | CD274 | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | PD-L1 | CD274 | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | PD-L1 | CD274 | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | MIC-A | MICA | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | MIC-A | MICA | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | MIC-A | MICA | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | MIC-B | MICB | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | MIC-B | MICB | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | HLA-A | HLA-A | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | HLA-DRA | HLA-DRA | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | HLA-A | HLA-A | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | HLA-B | HLA-B | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | HLA-B | HLA-B | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | HLA-B | HLA-B | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | HLA-C | HLA-C | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | HLA-C | HLA-C | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | HLA-C | HLA-C | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | HLA-E | HLA-E | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | HLA-F | HLA-F | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | CDKN1A | CDKN1A | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | CD40 | CD40 | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | BIRC5 | BIRC5 | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | IL-8 | CXCL8 | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | IL-22 | IL22 | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | FOS | FOS | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | FoxP3 | FOXP3 | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Mocetinostat | HELIOS | IKZF2 | cell lines | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | PD-L1 Ab | Tregs | NA | mouse model | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | PD-L1 Ab | HELIOS | NA | mouse model | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | PD-L1 Ab | HELIOS | NA | mouse model | 29124315 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | NA | JAK2 | JAK2 | patients | 29082853 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | NA | JAK3 | JAK3 | patients | 29082853 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | Nivolumab | ctDNA(circulating tumourederived DNA) | NA | clinical trail phase 1b | 29078173 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | mRNA-based vaccination | TLR-7 | TLR7 | clinical trail | 28123889 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | SAR | STAT1 | STAT1 | Cell lines | 29467274 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | SAR | STAT3 | STAT3 | Cell lines | 29467274 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | SAR | PD-L1 | CD274 | Cell lines | 29467274 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | nivolumab | IFNG | IFNG | clinical trail | 29383037 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | NK cells | Natural killer cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | NK cells | Natural killer cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD8+ T cells | Naive CD8+ T cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD8+ T cells | Effector CD8+ memory T (Tem) cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD8+ T cells | Exhausted CD8+ T cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD8+ T cells | CD8+ T cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD8+ T cells | CD8+ cytotoxic T cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | B cells | B cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | B cells | Transitional B cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | B cells | Memory B cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | B cells | Germinal center B cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | B cells | Regulatory B cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | B cells | Atypical memory B cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | B cells | Follicular B cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | B cells | Marginal zone B cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD4+ CD25+ cells | CD4-CD28+ T cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD4+ CD25+ cells | CD4-CD28- T cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD4+ CD25+ cells | Activated CD4+ T cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD4+ CD25+ cells | CD4+ T cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD4+ CD25+ cells | CD4+CD25+ regulatory T cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD4+ CD25+ cells | CD4-CD28+ T cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD4+ CD25+ cells | CD4-CD28- T cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD4+ CD25+ cells | Activated CD4+ T cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD4+ CD25+ cells | CD4+ T cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD4+ CD25+ cells | CD4+CD25+ regulatory T cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | PD-1 | PDCD1 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CTLA-4 | CTLA4 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | TIM-3 | HAVCR2 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | FoxP3+ T cells | Regulatory T (Treg) cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | FoxP3+ T cells | T cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | FoxP3+ T cells | CD4+ T cell | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CCL3 | CCL3 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CCL4 | CCL4 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CCL4 | CCL4 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CCL21a | CCL21 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CCL19 | CCL19 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CCL5 | CCL5 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | IL15 | IL15 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | IL18 | IL18 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | Tbx21 | TBX21 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | Gata3 | GATA3 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | Ifna1 | IFNA1 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | Ifna2 | IFNA2 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | Ifna4 | IFNA4 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD8a | CD8A | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD8b1 | CD8B | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | Gzmk | GZMK | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | Gzmm | GZMM | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD27 | CD27 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD28 | CD28 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | Fas-L | FASLG | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD1d2 | NA | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | Btla | BTLA | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | Ltk | LTK | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | IL-10 | IL10 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | FoxP3 | FOXP3 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | Ltf | LTF | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | Klra21 | NA | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | H60a | NA | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | Tnfsf18 | TNFSF18 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | Bcl6 | BCL6 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | Egr3 | EGR3 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD46 | CD46 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | Ncr1 | NCR1 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | Klra5 | NA | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CCL11 | CCL11 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | IL12rb2 | IL12RB2 | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | anti-PD-1 | CD59b | NA | Mouse model | 29339375 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | telomerase peptide GV1002 | Human telomerase reverse transcriptase (hTERT) | NA | clinical trail | 28123886 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | miR-26a-EZH2 | miR-26a | NA | mouse model | 28123882 | Details | NA | NA | NA | NA |
| Non Small Cell Lung Cancer | NSCLC | miR-26a-EZH2 | miR-26a | NA | cell lines | 28123882 | Details | NA | NA | NA | NA |
| Non Small Cell Lung Cancer | NSCLC | durvalumab | IFNγ | IFNG | clinical trial phase 1b/2 | 29716923 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | durvalumab | CD274 | CD274 | clinical trial phase 1b/2 | 29716923 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | durvalumab | LAG3 | LAG3 | clinical trial phase 1b/2 | 29716923 | Details |  |  |  |  |
| Non Small Cell Lung Cancer | NSCLC | durvalumab | CXCL9 | CXCL9 | clinical trial phase 1b/2 | 29716923 | Details |  |  |  |  |